Annual Accounts Payable
$4.72 M
-$3.55 M-42.90%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual accounts payable is $4.72 million, with the most recent change of -$3.55 million (-42.90%) on December 31, 2023.
- During the last 3 years, FATE annual accounts payable has fallen by -$1.56 million (-24.89%).
- FATE annual accounts payable is now -45.20% below its all-time high of $8.61 million, reached on December 31, 2021.
Performance
FATE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.35 M
+$854.00 K+15.54%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly accounts payable is $6.35 million, with the most recent change of +$854.00 thousand (+15.54%) on September 30, 2024.
- Over the past year, FATE quarterly accounts payable has increased by +$643.00 thousand (+11.27%).
- FATE quarterly accounts payable is now -53.19% below its all-time high of $13.56 million, reached on June 30, 2020.
Performance
FATE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FATE Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -42.9% | +11.3% |
3 y3 years | -24.9% | -35.6% |
5 y5 years | +12.2% | +22.7% |
FATE Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -45.2% | at low | -44.5% | +34.5% |
5 y | 5-year | -45.2% | at low | -53.2% | +70.8% |
alltime | all time | -45.2% | +631.6% | -53.2% | +884.3% |
Fate Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $6.35 M(+15.5%) |
Jun 2024 | - | $5.50 M(-18.8%) |
Mar 2024 | - | $6.76 M(+43.4%) |
Dec 2023 | $4.72 M(-42.9%) | $4.72 M(-17.3%) |
Sep 2023 | - | $5.71 M(-24.0%) |
Jun 2023 | - | $7.51 M(-23.8%) |
Mar 2023 | - | $9.86 M(+19.2%) |
Dec 2022 | $8.27 M(-4.0%) | $8.27 M(-13.8%) |
Sep 2022 | - | $9.59 M(+13.9%) |
Jun 2022 | - | $8.42 M(-26.4%) |
Mar 2022 | - | $11.44 M(+32.9%) |
Dec 2021 | $8.61 M(+37.1%) | $8.61 M(+33.7%) |
Sep 2021 | - | $6.44 M(+11.6%) |
Jun 2021 | - | $5.77 M(-35.9%) |
Mar 2021 | - | $9.00 M(+43.2%) |
Dec 2020 | $6.28 M(+7.9%) | $6.28 M(+69.0%) |
Sep 2020 | - | $3.72 M(-72.6%) |
Jun 2020 | - | $13.56 M(+162.2%) |
Mar 2020 | - | $5.17 M(-11.1%) |
Dec 2019 | $5.82 M | $5.82 M(+1.9%) |
Sep 2019 | - | $5.71 M(+5.6%) |
Jun 2019 | - | $5.41 M(+0.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $5.37 M(+27.6%) |
Dec 2018 | $4.21 M(+150.6%) | $4.21 M(-19.7%) |
Sep 2018 | - | $5.24 M(+49.2%) |
Jun 2018 | - | $3.51 M(+62.5%) |
Mar 2018 | - | $2.16 M(+28.7%) |
Dec 2017 | $1.68 M(+79.7%) | $1.68 M(-23.7%) |
Sep 2017 | - | $2.20 M(+86.7%) |
Jun 2017 | - | $1.18 M(-52.3%) |
Mar 2017 | - | $2.47 M(+164.5%) |
Dec 2016 | $934.00 K(-6.2%) | $934.00 K(-22.2%) |
Sep 2016 | - | $1.20 M(-39.9%) |
Jun 2016 | - | $2.00 M(+1.2%) |
Mar 2016 | - | $1.98 M(+98.3%) |
Dec 2015 | $996.00 K(+54.4%) | $996.00 K(-22.2%) |
Sep 2015 | - | $1.28 M(-15.1%) |
Jun 2015 | - | $1.51 M(+18.6%) |
Mar 2015 | - | $1.27 M(+97.1%) |
Dec 2014 | $645.00 K(-5.4%) | $645.00 K(-44.3%) |
Sep 2014 | - | $1.16 M(+18.1%) |
Jun 2014 | - | $980.00 K(-26.3%) |
Mar 2014 | - | $1.33 M(+95.0%) |
Dec 2013 | $682.00 K(-44.5%) | $682.00 K(-44.5%) |
Dec 2012 | $1.23 M | $1.23 M |
FAQ
- What is Fate Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Fate Therapeutics?
- What is Fate Therapeutics annual accounts payable year-on-year change?
- What is Fate Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Fate Therapeutics?
- What is Fate Therapeutics quarterly accounts payable year-on-year change?
What is Fate Therapeutics annual accounts payable?
The current annual accounts payable of FATE is $4.72 M
What is the all time high annual accounts payable for Fate Therapeutics?
Fate Therapeutics all-time high annual accounts payable is $8.61 M
What is Fate Therapeutics annual accounts payable year-on-year change?
Over the past year, FATE annual accounts payable has changed by -$3.55 M (-42.90%)
What is Fate Therapeutics quarterly accounts payable?
The current quarterly accounts payable of FATE is $6.35 M
What is the all time high quarterly accounts payable for Fate Therapeutics?
Fate Therapeutics all-time high quarterly accounts payable is $13.56 M
What is Fate Therapeutics quarterly accounts payable year-on-year change?
Over the past year, FATE quarterly accounts payable has changed by +$643.00 K (+11.27%)